April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
In Vivo and In Vitro Feasibility Studies of Intraocular Use of FocalSeal® to Close Retinal Breaks in Porcine and Rabbit Eyes
Author Affiliations & Notes
  • Sujin Hoshi
    Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
  • Fumiki Okamoto
    Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
  • Yuichi Kaji
    Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
  • Mikki Arai
    Department of Ophthalmology, Arai Eye Clinic, Fukuoka, Japan
  • Tatsuo Hirose
    The Schepens Eye Research Institute, Harvard Medical School, Boston, MA
  • Tetsuro Oshika
    Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
  • Footnotes
    Commercial Relationships Sujin Hoshi, None; Fumiki Okamoto, Genzyme (F); Yuichi Kaji, None; Mikki Arai, None; Tatsuo Hirose, None; Tetsuro Oshika, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1092. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sujin Hoshi, Fumiki Okamoto, Yuichi Kaji, Mikki Arai, Tatsuo Hirose, Tetsuro Oshika; In Vivo and In Vitro Feasibility Studies of Intraocular Use of FocalSeal® to Close Retinal Breaks in Porcine and Rabbit Eyes. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1092.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: FocalSeal® is an absorbable polyethylene glycol-based synthetic hydrogel sealant. This liquid is polymerized under visible xenon illumination, and forms clear, flexible, and firmly adherent hydrogel. In this study, we evaluated the intraocular biocompatibility of the sealant and explored its efficacy for closing retinal breaks.

Methods: An in vitro study was conducted to assess the efficacy of FocalSeal® in enucleated porcine eyes, and an in vivo study was performed to evaluate its safety in Dutch pigmented rabbit eyes. In the in vitro study, retinal detachment with a hole was created in porcine eyecups after the vitreous gel was removed. FocalSeal® was applied to cover the hole, and was polymerized with 60-second application of xenon light. The strength of the retinal adhesion was tested by forcefully pouring balanced slat solution (BSS) to the retinal hole. The pH of FocalSeal® soaked in the BSS, incubated at 37°C, was measured periodically for 72 hours. In the in vivo study, FocalSeal® was injected into the vitreous cavity of left eyes of the rabbits. Ophthalmologic examinations were performed and bilateral electroretinograms (ERG) were recorded simultaneously before and 4 weeks after injection. Both eyes were enucleated for histological evaluation.

Results: Adhesion of FocalSeal® to the retina was relatively strong. The forceful application of BSS to the retinal hole covered with FocalSeal® did not detach the retina, while the retinal hole without FocalSeal® detached immediately after BSS application. The pH of BSS containing FocalSeal® was between 7.2 to 8.0. With slit lamp microscopy and funduscopy, no inflammatory reaction was observed in the eyes during the 4-week follow-up after treatment. ERGs recorded before and after injection showed typical patterns. There was no significant difference in the amplitude or implicit time of the a-waves, b-waves, and oscillatory potentials of the ERG between the study and control groups. Histological examination with a light microscope did not reveal any abnormality or inflammation in either group at the end of the study.

Conclusions: FocalSeal® appeared to effectively seal retinal breaks in our in vitro experiment, and the in vivo studies indicated that FocalSeal® was not toxic to the eye.

Keywords: 697 retinal detachment • 762 vitreoretinal surgery  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×